IL23R and neoplasm: IL-23R expression was examined in a panel of normal/tumor matched NSCLC patient samples using RT-PCR Representative images are shown in Figure 1A. A summary of the results is shown in Figure 1B. Overall, there was an increase observed in IL-23R (23/37, 62%) in the tumor compared with normal.